Werewolf Therapeutics, Inc.
HOWL • NASDAQ • Stock Fundamentals
Werewolf Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Daniel J. Hicklin, with a market cap of $19.2M.
Market Cap$19.2M
Employees46.0
CEODaniel J. Hicklin
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View reportNext EarningsAug 13, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Werewolf Therapeutics, Inc. FAQ
Common questions about Werewolf Therapeutics, Inc.
Werewolf Therapeutics, Inc. (HOWL) has a market capitalization of $19.2M and trades on NASDAQ.
Werewolf Therapeutics, Inc. has approximately 46 employees.